What is Polaryx Therapeutics, Inc. 's deferred tax assets?

Polaryx Therapeutics, Inc. (PLYX) reported deferred tax assets of $4.74M in Q4 2025.

What does deferred tax assets mean?

Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.

Polaryx Therapeutics, Inc. PLYX Deferred Tax Assets

Deferred Tax Assets at other companies

Core & MainCNM

$89M+2.3%

PentairPNR

$45.7M+0.2%

CNH Industrial N.V.CNH

$15M-55.9%

EquifaxEFX

$401.9M+17.3%

Sanmina CorpSANM

$326.42M+110%

RHP

Ryman Hospitality PropertiesRHP

$61.96M-8.3%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$115.64M—

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's deferred tax assets?: Polaryx Therapeutics, Inc. (PLYX) reported deferred tax assets of $4.74M in Q4 2025.
What does deferred tax assets mean?: Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.